Dermatoneuro syndrome
Date
2016-06
Journal Title
Journal ISSN
Volume Title
Repository Usage Stats
views
downloads
Citation Stats
Attention Stats
Abstract
Type
Department
Description
Provenance
Subjects
Citation
Permalink
Published Version (Please cite this version)
Publication Info
Liu, Andrew, Kathleen Suozzi, David Y Hwang, Jeremy J Moeller, Rossitza Lazova and Daniel DiCapua (2016). Dermatoneuro syndrome. Neurology: Clinical Practice, 6(3). pp. e27–e29. 10.1212/cpj.0000000000000221 Retrieved from https://hdl.handle.net/10161/20243.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Collections
Scholars@Duke
Andrew John Liu
While striving to provide excellent clinical care, I also have several research interests:
1. Establish novel diagnostic biomarkers along with new therapeutic targets in Alzheimer's Disease (AD) and comorbid Cerebral Amyloid Angiopathy. I currently serve as the Associate Biomarker Core lead in the Duke-UNC Alzheimer's Disease Research Center (ADRC). I am also the site Principal Investigator (PI) of a Biogen sponsored phase 2 clinical trial, CELIA (BIIB080), that targets AD-related tau through an Anti-sense oligonucleotide (ASO) mechanism. Additionally, I am the site PI of the ALNYLAM sponsored phase 2 clinical trial. This trial knocks down the expression of APP through an ASO mechanism to potentially treat Cerebral Amyloid Angiopathy (CAA).
2. Investigate a neurodevelopmental disorder, Tuberous Sclerosis Complex (TSC), which has the potential to provide insight into the pathophysiological mechanism of AD-related tau. I have published several papers on this subject and am currently the PI of the Ann B. Bussell award that is following TSC patients longitudinally to determine if TSC is an AD-related tauopathy.
3. I am interested discovering new biomarkers to diagnose various neurodegenerative diseases. I am a co-Investigator with NCCU colleagues. We have published several new tau epitopes as potential biomarkers in diagnosing AD at earlier stages and have applied for several government funding mechanisms to continue this work.
Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.